Industry Rank | Company | Symbol | Average Rec. | Market Cap* | Last
Qtr EPS | This Qtr Est. EPS | Earnings Growth This Year Est. | More
Info |
|---|
| 1 | | JNJ | 2.0 | 199.6B | 1.2 | 1.1 | N/A |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 2 | Pfizer Inc | PFE | 2.8 | 181.9B | 0.7 | 0.5 | 4.4% |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 3 | Johnson & Johnson | JNJ | 1.9 | 179.9B | 1.2 | 1.0 | 7.4% |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 4 | | PFE | 2.8 | 129.9B | 0.6 | 0.6 | N/A |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 5 | Merck & Co. Inc. | MRK | 2.3 | 106.8B | 0.8 | 0.7 | 15.9% |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 6 | | DNA | 2.2 | 103.9B | 0.8 | 0.9 | N/A |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 7 | | ABT | 2.0 | 90.6B | 0.8 | 0.8 | N/A |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 8 | Abbott Laboratories | ABT | 2.1 | 82.9B | 0.6 | 0.7 | 11.9% |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 9 | Genentech Inc | DNA | 2.0 | 80.0B | 0.7 | 0.7 | 30.5% |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |
| 10 | | MRK | 2.4 | 78.0B | 0.9 | 0.8 | N/A |
Quote
,
Chart
,
Profile
,
Reports
,
Research
,
SEC
,
Msgs
,
Insider
,
Financials
,
Analyst Ratings |